Target the Gene, Silence the Diseaseđź”’ SSL Verified
Live Data Status: |News & Media
Welcome to the detailed analysis for arrowheadpharma.com. This domain is officially recognized as Arrowhead Pharmaceuticals Home | Arrowhead Pharmaceuticals, Inc.. According to their official web presence, their primary focus is: "Changing the way diseases are treated, Arrowhead pharmaceuticals uses innovative, scientific methods to discover, develop, and deliver therapies and solutions.".
Table of Contents
- ↓ RNAi technology makes it possible to target the genes that cause disease.
- ↓ Above & Beyond
- ↓ Our Pipeline*
- ↓ Plozasiran
- ↓ Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Plozasiran in Adults with Severe Hypertriglyceridemia (SHASTA-3)
- ↓ Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Plozasiran in Adults with Severe Hypertriglyceridemia (SHASTA-4)
- ↓ Top Alternatives to arrowheadpharma.com
- Tech Stack
- Custom Built / Unknown
- Link Profile
- Internal Pages: 64Outbound Links: 13
- Localization
- en
6-Month Traffic Trend Estimate
M1
M2
M3
M4
M5
M6
Estimated Market Value
$189
Based on domain age, authority, and keyword relevance.
TLD Availability Risk
- arrowheadpharma.comAvailable
- arrowheadpharma.netAvailable
- arrowheadpharma.orgAvailable
- arrowheadpharma.ioAvailable
- arrowheadpharma.coTaken
- arrowheadpharma.aiTaken
Official Contact & Profiles
Content Snippets from arrowheadpharma.com
"Treating diseases with significant unmet needs demands a unique approach at a fast pace, that’s exactly where we thrive. Our targeted RNAi molecule, TRiM™, platform leverages a natural pathway to “silence” genes causing disease. With drug candidates in a growing number of disease areas, TRiM™ has shown it can target genes wherever they are."
"Every day we can save in our development timeline is one day earlier a person may benefit from our future therapies."
"We go farther when we work together to reimagine how therapeutics are developed and delivered."
"We don’t let uncertainty keep us from tackling big questions and finding meaningful solutions."
Key Topics & Focus Areas for arrowheadpharma.com:
RNAi technology makes it possible to target the genes that cause disease.
Above & Beyond
Our Pipeline*
Plozasiran
Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Plozasiran in Adults with Severe Hypertriglyceridemia (SHASTA-3)
Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Plozasiran in Adults with Severe Hypertriglyceridemia (SHASTA-4)
By comparing arrowheadpharma.com to other leading websites in its niche, marketers and researchers can identify key traffic sources and growth opportunities. Explore our related resources below to find websites similar to arrowheadpharma.com.
Frequently Asked Questions
Is arrowheadpharma.com a safe and secure website?
Yes, according to our latest analysis, we detected a valid SSL certificate ensuring a secure connection.
What is the authority score of arrowheadpharma.com?
As of August 21, 2026, arrowheadpharma.com holds an estimated domain authority score of 35/100 based on our VisitRank tracking algorithms.
What are the top alternatives to arrowheadpharma.com?
You can find the best alternatives and similar sites to arrowheadpharma.com in our explore section, which includes competitors in the News & Media sector.
Data Sources & Methodology: DNS telemetry and routing records are resolved via live root servers. Market valuation estimates are computed algorithmically based on proprietary historical indexation multiples and standardized digital asset appraisal methodologies.
Common Misspellings & Typo Domains for arrowheadpharma.com:
arrowheadpharma.comarowheadpharma.comarrrowheadpharma.comerrowheadpharma.comarrowhaadpharma.comarrowheedpharma.comarrowheadpherma.comarrowheadpharme.comaerowheadpharma.comadrowheadpharma.com